The enterprise platform to build, deliver, and govern AI
Watch the 15 minute on-demand demo to get an overview of the Domino Enterprise AI Platform.
AI ROI has become one of the most debated topics in enterprise technology discussions as organizations invest heavily in generative AI while struggling to prove tangible business value. Boards and executives see growing spend, rising experimentation, and expanding AI initiatives, yet many teams cannot clearly explain what return they are getting or how success should be measured. This gap between investment and evidence has created skepticism, slowed scaling, and increased pressure on AI leaders to justify decisions with more than technical benchmarks.
This blog examines why measuring GenAI value is so difficult in practice. It clarifies what actually counts as ROI, what does not, and how enterprises can adopt realistic frameworks that connect GenAI efforts to defensible business outcomes.
Enterprise spending on GenAI continues to accelerate, but confidence in results has not kept pace. Many organizations report early wins in experimentation while still failing to demonstrate sustained impact across core operations.
One major challenge is the disconnect between technical performance and business relevance. Models may generate impressive outputs, yet those outputs are not consistently tied to improved business processes or decisions. Without reliable data quality and clearly defined baselines, teams cannot determine whether improvements are driven by AI-driven changes or by unrelated operational factors.
Traditional ROI models assume stable inputs, predictable outputs, and linear cost structures. GenAI breaks these assumptions. Variable usage, evolving prompts, and ongoing model iteration make static calculations insufficient. As a result, the ROI of generative AI is often assessed using incomplete or misleading proxies rather than outcome-based measures.
To measure value effectively, enterprises must distinguish between financial returns that can be quantified and strategic benefits that accrue over time.
Hard ROI refers to outcomes that can be directly measured in financial terms. Examples include cost savings from automating manual tasks, reduced cycle times that lower operating expenses, and incremental revenue tied to AI-enabled products. In GenAI contexts, this may involve tracking inference costs per million tokens against productivity gains or reduced external spend. These metrics anchor return on investment ROI in concrete evidence.
Soft ROI reflects benefits that are harder to quantify but still critical. Faster decision-making, improved customer interactions, and increased organizational learning all fall into this category. While soft ROI does not immediately appear on a balance sheet, it often enables long term advantages by strengthening AI strategy and organizational readiness for future AI solutions.
Many organizations rely on indicators that appear meaningful but fail to demonstrate real value.
Metrics such as model accuracy improvements, user adoption counts, or pilot completion rates are frequently mistaken for ROI. While useful for development tracking, they do not prove that AI investment is delivering measurable business outcomes. Focusing on these signals can obscure whether AI tools are actually changing decisions or reducing costs.
Another common mistake is evaluating ROI before systems are integrated into production workflows. Measuring isolated pilots ignores downstream effects and hides the cumulative costs of deployment, governance, and scaling. This contributes to confusion about the ROI of GenAI and undermines confidence among business leaders.
Even when benefits are real, hidden costs can significantly reduce net returns.
Enterprises often assume that larger models automatically deliver better results. In practice, LLM cost vs performance tradeoffs are highly context dependent. Overprovisioning compute or selecting unnecessarily complex models can quickly make solutions less cost effective, especially when usage grows.
Inference costs frequently exceed expectations once systems move into production. LLM inference expenses accumulate rapidly as usage scales across teams and applications. Without careful monitoring, AI investment can outpace realized value, particularly in industry specific deployments with high availability requirements.
The inability to demonstrate ROI is rarely due to a lack of effort. More often, it stems from structural measurement challenges.
Many teams launch AI initiatives without establishing a clear pre-AI baseline. Without understanding existing performance, it becomes impossible to attribute improvements to AI initiatives rather than to parallel process changes or staffing shifts.
GenAI systems rarely operate in isolation. They interact with data pipelines, human workflows, and downstream applications. This complexity makes it difficult to isolate causal impact, especially when multiple AI solutions influence the same business processes. As organizations adopt agentic AI, attribution becomes harder because outcomes emerge from coordinated actions across models and workflows.
Enterprises that succeed in measuring value adopt frameworks designed for uncertainty and iteration.
Rather than evaluating each use case independently, organizations benefit from a portfolio view. This approach balances high-impact projects with experimental efforts and aligns evaluation with overall AI mode maturity. Portfolio thinking also supports better prioritization of AI initiatives across functions.
Realistic ROI frameworks account for phased returns. Early stages may focus on learning and capability building, while later stages deliver more direct financial impact. Aligning expectations around time horizons helps business leaders support sustained AI investment instead of demanding immediate results.
Domino’s unified platform approach helps enterprises connect experimentation to production outcomes in a way that supports measurable GenAI ROI. By standardizing development, deployment, and governance across teams, organizations gain consistent visibility into costs, performance, and usage across AI driven workloads. This shared foundation reduces fragmentation, making it easier to understand where value is created and where spend accumulates as GenAI systems scale.
Centralized lifecycle management also lets teams apply MLOps best practices from the start, including reproducibility, auditability, and controlled promotion into production. With clear lineage across data, models, and deployments, enterprises can tie AI investment directly to business outcomes rather than relying on proxy metrics. This structure supports accountability across AI initiatives, helping business leaders evaluate which use cases deliver sustainable ROI over the long term.
Hard ROI refers to financial outcomes that can be directly measured, such as reduced labor costs or lower operational spend. Soft ROI captures strategic benefits like faster innovation, improved customer experiences, and stronger decision quality. Both matter. Hard ROI proves near-term value, while soft ROI supports long term competitiveness and resilience as generative AI capabilities mature.
Most failures stem from weak baselines, premature measurement, and reliance on vanity metrics. Hidden costs, unclear ownership, and poor integration into core workflows also contribute. Without aligning AI strategy to business outcomes and tracking costs alongside impact, enterprises struggle to demonstrate value even when systems are technically successful.
Meaningful ROI usually emerges over months rather than weeks. Early pilots validate feasibility, but sustained returns appear after GenAI is embedded into production workflows, governed consistently, and scaled responsibly. Time is required to refine prompts, improve data quality, and optimize operating costs.
Effective measurement focuses on business outcomes rather than model metrics alone. Enterprises should track cost savings, productivity gains, time to decision, and total AI investment over time. Monitoring usage patterns, inference spend, and downstream impact helps link AI driven changes to real business results.

Domino Data Lab empowers the largest AI-driven enterprises to build and operate AI at scale. Domino’s Enterprise AI Platform provides an integrated experience encompassing model development, MLOps, collaboration, and governance. With Domino, global enterprises can develop better medicines, grow more productive crops, develop more competitive products, and more. Founded in 2013, Domino is backed by Sequoia Capital, Coatue Management, NVIDIA, Snowflake, and other leading investors.
Watch the 15 minute on-demand demo to get an overview of the Domino Enterprise AI Platform.
In this article
Watch the 15 minute on-demand demo to get an overview of the Domino Enterprise AI Platform.